249A Stock Overview
Engages in the management of acupuncture and bone setting clinics in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Human Adjust Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,700.00 |
| 52 Week High | JP¥1,700.00 |
| 52 Week Low | JP¥1,700.00 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| 249A | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -0.4% |
| 1Y | n/a | -6.5% | 11.4% |
Return vs Industry: Insufficient data to determine how 249A performed against the JP Healthcare industry.
Return vs Market: Insufficient data to determine how 249A performed against the JP Market.
Price Volatility
| 249A volatility | |
|---|---|
| 249A Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 249A's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: Insufficient data to determine 249A's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | n/a | human-adjust.co.jp |
Human Adjust Co.,Ltd. engages in the management of acupuncture and bone setting clinics in Japan. It also provides acupuncture and bone setting clinic store management consulting services; and holds seminars for acupuncture and bone setting clinics.
Human Adjust Co.,Ltd. Fundamentals Summary
| 249A fundamental statistics | |
|---|---|
| Market cap | JP¥510.00m |
| Earnings (TTM) | JP¥27.00m |
| Revenue (TTM) | JP¥1.95b |
18.9x
P/E Ratio0.3x
P/S RatioIs 249A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 249A income statement (TTM) | |
|---|---|
| Revenue | JP¥1.95b |
| Cost of Revenue | JP¥1.29b |
| Gross Profit | JP¥660.00m |
| Other Expenses | JP¥633.00m |
| Earnings | JP¥27.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 90.00 |
| Gross Margin | 33.79% |
| Net Profit Margin | 1.38% |
| Debt/Equity Ratio | 603.0% |
How did 249A perform over the long term?
See historical performance and comparison